SCHEMBL16947012

SCHEMBL16947012

c1ccc(-c2ccc(N(c3ccccc3-c3ccc(-c4ccc5c6ccccc6n(-c6ccccc6)c5c4)cc3)c3cccc4ccccc34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ MAPK14 Q16539 1/20 0.31
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ TSPO P30536 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ METAP2 P50579 1/20 0.31
▸ KMT2A Q03164 2/20 0.30
▸ IL1R1 P14778 1/20 0.30
▸ RXRA P19793 1/20 0.30
▸ RXRB P28702 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18365578 0.98 KDM4E (0.36) L3MBTL1KDM4EATMCA12CA1
SCHEMBL18365628 0.97 KDM4E (0.35) L3MBTL1KDM4EATMCA12CA1
SCHEMBL16947008 0.97 KDM4E (0.40) L3MBTL1KDM4EATMCA12CA1
SCHEMBL17056498 0.97 L3MBTL1 (0.40) L3MBTL1KDM4EATMCA12CA1
SCHEMBL17056720 0.95 KDM4E (0.35) L3MBTL1KDM4EATMCA12CA1
SCHEMBL17056489 0.94 KDM4E (0.37) L3MBTL1KDM4EATMCA12CA1
SCHEMBL18365574 0.93 KDM4E (0.43) L3MBTL1KDM4EATMCA12CA1
SCHEMBL18365576 0.93 KDM4E (0.37) L3MBTL1KDM4EATMCA12CA1
SCHEMBL18561206 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EATMCA12CA1
SCHEMBL17040856 0.92 KDM4E (0.37) L3MBTL1KDM4EATMCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-01-12 — — US disclosed
WO-2015111888-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2015-07-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012212-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, OR51E2, PIEZO1 L3MBTL1 297/4885KDM4E 984/4885ATM 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback